IronBridge Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-23,787
Closed -$3.84M 32
2022
Q4
$3.84M Buy
+23,787
New +$3.65M 3.17% 12
2022
Q1
Sell
-484
Closed -$65K 39
2021
Q4
$65K Buy
484
+1
+0.2% +$118 0.03% 61
2021
Q3
$52K Hold
483
0.03% 56
2021
Q2
$54K Buy
483
+1
+0.2% +$113 0.03% 60
2021
Q1
$52K Hold
482
0.03% 60
2020
Q4
$52K Buy
+482
New +$46.3K 0.04% 55

Other funds holding ABBV

IronBridge Private Wealth's ABBV Position: Q1 2023 in Review

IronBridge Private Wealth sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 23,787 shares — an estimated $3.84M sold.

IronBridge Private Wealth first reported a position in ABBV in Q4 2020 and held it in 6 quarters. The position peaked at $3.84M in Q4 2022. 3,139 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • IronBridge Private Wealth reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • IronBridge Private Wealth sold 23,787 AbbVie shares in Q1 2023, an estimated $3.84M.
  • IronBridge Private Wealth first reported a position in AbbVie in Q4 2020 and held it in 6 quarters.
  • IronBridge Private Wealth's AbbVie position peaked at $3.84M in Q4 2022.
  • 3,139 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on IronBridge Private Wealth's 13F filing for Q1 2023, filed 12 Apr 2023.